Alliancebernstein L.P. Agios Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 60,792 shares of AGIO stock, worth $2.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,792

Previous 65,122 6.65%

Holding current value

$2.15 Million

Previous $2.81 Million 3.85%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$41.19 - $49.72 $178,352 - $215,287	-4,330 Reduced 6.65%	60,792 $2.7 Million
Q2 2024 Aug 14, 2024	SELL	$27.55 - $48.83 $168,055 - $297,863	-6,100 Reduced 8.56%	65,122 $2.81 Million
Q1 2024 May 14, 2024	SELL	$21.32 - $34.81 $50,315 - $82,151	-2,360 Reduced 3.21%	71,222 $2.08 Million
Q4 2022 Feb 14, 2023	BUY	$24.81 - $31.52 $545 - $693	22 Added 0.03%	73,582 $2.07 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $34.81 $5,336 - $6,962	200 Added 0.27%	73,560 $2.14 Million
Q3 2021 Nov 10, 2021	SELL	$41.92 - $58.18 $25,152 - $34,908	-600 Reduced 0.81%	73,360 $3.39 Million
Q2 2021 Jul 30, 2021	BUY	$52.06 - $61.27 $2.2 Million - $2.59 Million	42,318 Added 133.74%	73,960 $4.08 Million
Q1 2021 May 06, 2021	SELL	$44.23 - $57.5 $1.57 Million - $2.04 Million	-35,400 Reduced 52.8%	31,642 $1.63 Million
Q4 2020 Feb 08, 2021	SELL	$33.21 - $46.54 $1.53 Million - $2.14 Million	-46,052 Reduced 40.72%	67,042 $2.91 Million
Q3 2020 Nov 12, 2020	BUY	$33.87 - $55.93 $1.03 Million - $1.7 Million	30,454 Added 36.85%	113,094 $3.96 Million
Q2 2020 Aug 13, 2020	SELL	$34.45 - $53.48 $413,813 - $642,401	-12,012 Reduced 12.69%	82,640 $4.42 Million
Q1 2020 May 14, 2020	BUY	$31.52 - $53.81 $2.12 Million - $3.62 Million	67,360 Added 246.81%	94,652 $3.36 Million
Q4 2019 Feb 18, 2020	SELL	$30.08 - $50.59 $3.53 Million - $5.93 Million	-117,200 Reduced 81.11%	27,292 $1.3 Million
Q3 2019 Nov 14, 2019	BUY	$32.4 - $49.58 $3.89 Million - $5.95 Million	120,000 Added 489.96%	144,492 $4.68 Million
Q2 2019 Aug 14, 2019	SELL	$46.17 - $68.1 $859,685 - $1.27 Million	-18,620 Reduced 43.19%	24,492 $1.22 Million
Q1 2019 May 14, 2019	BUY	$45.92 - $67.67 $893,144 - $1.32 Million	19,450 Added 82.2%	43,112 $2.91 Million
Q4 2018 Feb 13, 2019	SELL	$42.73 - $76.53 $21,365 - $38,265	-500 Reduced 2.07%	23,662 $1.09 Million
Q3 2018 Nov 08, 2018	SELL	$71.67 - $91.95 $36,551 - $46,894	-510 Reduced 2.07%	24,162 $1.86 Million
Q2 2018 Aug 13, 2018	BUY	$73.22 - $99.55 $106,169 - $144,347	1,450 Added 6.24%	24,672 $2.08 Million
Q1 2018 May 14, 2018	BUY	$59.83 - $86.53 $94,531 - $136,717	1,580 Added 7.3%	23,222 $1.9 Million
Q4 2017 Feb 13, 2018	SELL	$52.12 - $72.33 $633,258 - $878,809	-12,150 Reduced 35.96%	21,642 $1.24 Million
Q3 2017 Nov 13, 2017	BUY	$54.89 - $67.12 $1.85 Million - $2.27 Million	33,792	33,792 $2.26 Million

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.94B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Agios Pharmaceuticals, Inc. Transaction History